SIIT Based on UST CDST in Patients With CD

NCT05861167 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

BIOLOGICAL: selective intensive induction therapy based on ustekinumab clinical decision-making tools

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University